Ke halaman utama

Bagaimana cara kerjanya

Kami telah mentransformasi proses pencarian klinik, membuatnya sederhana, cepat, dan personal.
Jawab beberapa pertanyaanIsi formulir singkat untuk memberi tahu kami tentang kondisi serta kebutuhan medis Anda.
Dapatkan penawaran khusus3 klinik, dipilih berdasarkan jawaban Anda, memberikan rencana perawatan dan penawaran harga yang disesuaikan.
Pilih opsi terbaikBandingkan penawaran dan pilih klinik yang paling cocok untuk Anda.
Anda juga dapat melihat seluruh 8 klinik di bawah ini.
820К+ pasien telah mendapatkan bantuan sejak 2014
50 negara
1,500 klinik
6K+ ulasan
3K+ dokter berkualifikasi

Berapa Biaya Prosedur Diagnostik dan Perawatan Adenokarsinoma sigmoid di Israel? Cari Tahu Sekarang

Harga rata-rata untuk diagnosis dan perawatan Adenokarsinoma sigmoid di Israel adalah $17,687, harga minimum $15,000, dan harga maksimum $21,620.
IsraelTurkiAustria
Kolektomi (reseksi usus besar)dari $20,500dari $6,912dari $22,000
Kemoterapi untuk kanker payudaradari $22,500dari $1,200dari $15,000
Terapi radiasi untuk kanker kolorektal-dari $7,000dari $12,000
Data diverifikasi oleh Bookimed per May 2026, berdasarkan permintaan pasien dan penawaran resmi dari 99 klinik di seluruh dunia. Biaya median didasarkan pada faktur nyata (2025–2026) dan diperbarui setiap bulan. Harga aktual dapat bervariasi.

Temukan Klinik Adenokarsinoma sigmoid Terbaik di Israel: 8 Opsi Terverifikasi dan Harga

Klinik diperingkat oleh sistem cerdas Bookimed menggunakan analisis data science pada 5 kriteria utama.
Sourasky Medical Center (Ichilov)
Assuta Medical Center
Hadassah Medical Center
Rambam Medical Center
Soroka Medical Center

Dapatkan Penilaian Medis untuk Adenokarsinoma sigmoid di Israel: Konsultasikan dengan 18 Dokter Berpengalaman Sekarang

Lihat semua Dokter
terverifikasi

Pelles Sharon

23 tahun pengalaman

Direktur institut tumor gastrointestinal di Sourasky Medical Center – Dr. Sharon Peled berspesialisasi dalam pengobatan sistemik kanker saluran pencernaan.

  • Terlatih dalam kanker gastrointestinal di Royal Marsden Cancer Centre di London
  • Anggota Masyarakat Onkologi dan Radiologi Israel
  • Melakukan penelitian klinis tentang sikap pasien terhadap uji coba
  • Melakukan perawatan tingkat lanjut seperti HIPEC dan imunoterapi
terverifikasi

Ofer Merimsky

41 tahun pengalaman

Prof. Ofer Merimsky adalah spesialis onkologi terkemuka dalam tumor tulang dan jaringan lunak di Sourasky Medical Center. Keahliannya mencakup puluhan tahun, dengan kepemimpinan di komunitas onkologi global.

  • Kepala Departemen Tumor Tulang dan Jaringan Lunak
  • Ketua Asosiasi Onkolog Klinis Israel
  • Anggota ASCO dan ESMO, organisasi onkologi terkemuka di dunia
  • Menjalani pelatihan fellowship di Paris untuk perawatan sarkoma tingkat lanjut
  • Mengajar onkologi di Universitas Yerusalem
terverifikasi

Arnon Nagler Md

46 tahun pengalaman

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

terverifikasi

Almog Ben Yaacov

20 tahun pengalaman

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Bagikan konten ini

Video Kisah dari Pasien Bookimed

Dayana
I combined my vacation in Antalya with a check-up.
Prosedur: Pemeriksaan kesehatan wanita
Igor
It was great! Transfers, accommodation, treatment—all included.
Prosedur: Implan Gigi
Marina
Bookimed did everything for me. I didn't have to worry about anything.
Prosedur: Pemeriksaan kesehatan wanita
Diperbarui: 05/27/2022
Ditulis oleh
Anna Leonova
Anna Leonova
Head of Content Marketing Team
Penulis medis bersertifikat dengan pengalaman 10+ tahun, membangun konten tepercaya Bookimed, didukung Master di bidang Filologi dan wawancara ahli medis di seluruh dunia.
Fahad Mawlood
Editor Medis & Data Scientist
Dokter umum. Pemenang 4 penghargaan ilmiah. Pernah bertugas di Asia Barat. Mantan Pemimpin Tim tim medis yang mendukung pasien berbahasa Arab. Kini bertanggung jawab atas pengolahan data dan akurasi konten medis.
Fahad Mawlood Linkedin
Halaman ini mungkin menampilkan informasi terkait berbagai kondisi medis, perawatan, dan layanan kesehatan yang tersedia di berbagai negara. Perhatian: konten ini hanya untuk tujuan informasi dan tidak boleh diartikan sebagai nasihat atau panduan medis. Harap konsultasikan dengan dokter atau tenaga medis profesional sebelum memulai atau mengubah perawatan medis.

FAQ tentang Pengobatan Adenokarsinoma sigmoid di Israel

FAQ ini berasal dari pasien nyata yang mencari bantuan medis melalui Bookimed. Jawaban diberikan oleh koordinator medis berpengalaman dan perwakilan klinik terpercaya.

Is robotic or laparoscopic sigmoid colectomy for cancer available and widely used in Israeli hospitals?

Robotic and laparoscopic sigmoid colectomy for cancer are standard, widely available procedures in Israeli hospitals. JCI-accredited centers in Tel Aviv and Jerusalem utilize the Da Vinci system for precise tumor removal. These minimally invasive techniques are the preferred standard for treating sigmoid adenocarcinoma.

  • Available technologies: JCI-accredited facilities like Sourasky and Hadassah perform robotic-assisted and laparoscopic surgery.
  • Clinical success: Primary oncology centers in Tel Aviv report a 90% average success rate.
  • Surgical volume: Major Israeli hospitals perform between 30,000 and 92,000 surgical operations annually.
  • Recovery timeline: Minimal incisions often allow for hospital discharge within 2 to 3 days.

Bookimed Expert Insight: Israeli medical centers demonstrate a high level of surgical specialization where oncologists like Dr. Ofer Merimsky collaborate with surgical teams for complex cases. Large facilities like Sourasky and Assuta handle over 30,000 and 92,000 operations per year respectively. This high volume suggests that surgical teams maintain a high degree of proficiency in minimally invasive techniques.

Patient Consensus: Patients note that the small incisions lead to much less pain compared to traditional open surgery. They often express relief at how quickly they can walk and eat again after the procedure.

What are the typical post-operative recovery milestones for a sigmoid colectomy in Israeli centers?

Bowel function restoration and early mobilization define the Israeli sigmoid colectomy recovery timeline. Patients usually stay in the hospital for 3 to 7 days. Full functional recovery typically occurs within 4 to 8 weeks. Specialized centers often employ Enhanced Recovery After Surgery protocols to speed healing.

  • Hospital stay: Most patients remain hospitalized for 3 to 7 days post-procedure.
  • Early mobilization: Walking with assistance often starts within 24 hours to prevent complications.
  • Dietary progression: Clear liquids usually begin on day 1 or 2 after surgery.
  • Activity restrictions: Patients should avoid lifting over 7kg for at least 6 to 8 weeks.

Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center report a 90% success rate in oncology treatments. This high performance is often linked to the extreme specialization of their surgeons. For example, Dr. Joseph Klauzner has over 45 years of experience in colorectal procedures. Choosing a facility with such established surgical leadership often ensures more predictable recovery milestones.

Patient Consensus: Patients emphasize that frequent walking is the best way to manage gas pain and restart digestion. Many note a significant wave of fatigue hitting 2 to 4 weeks after returning home.

Which Israeli surgeons or hospitals are internationally accredited for colon-cancer care?

Israeli medical centers like Sourasky, Assuta, and Hadassah maintain Joint Commission International accreditation for colon cancer care. These facilities prioritize multidisciplinary treatment for sigmoid adenocarcinoma. Patients access specialists trained at premier global institutions like the Royal Marsden and University of Toronto.

  • Accredited hospitals: Sourasky, Hadassah, and Assuta hold prestigious Joint Commission International certification for safety.
  • Expert surgeons: Dr. Sharon Pelles at Sourasky specializes in complex colon cancer resections.
  • Advanced diagnostics: Facilities utilize PET/CT and complex oncology diagnostics for precise tumor staging.
  • Clinical excellence: Sourasky reports a 90% average success rate for oncology treatment protocols.

Bookimed Expert Insight: Israeli oncology centers like Sourasky and Hadassah manage immense patient volumes, exceeding 1,000,000 annual visits. This high frequency allows surgeons to refine techniques for complex sigmoid adenocarcinoma cases. Clinics like Assuta offer private-sector flexibility. This lets patients select specific senior surgeons for robotic-assisted colectomy procedures.

Patient Consensus: Patients note the seamless coordination during diagnostics, often completing biopsies and PET/CT scans within days. Many feel reassured by doctors who explain surgical steps in clear, empathetic English.

Will I need a temporary or permanent stoma after sigmoid cancer surgery in Israel?

Most patients undergoing sigmoid cancer surgery in Israel do not require a permanent stoma. Israeli surgeons prioritize primary anastomosis to reconnect the healthy bowel directly. A temporary stoma may be used for 6 to 12 weeks to protect the new connection while it heals properly.

  • Temporary stoma: Protects the anastomosis when healing concerns or emergency blockages exist.
  • Reversal timeline: Surgeons typically perform reversal surgery within 3 to 6 months.
  • Permanent stoma: Rarely needed unless cancer involves the anal sphincter or lower rectum.
  • Surgical methods: Laparoscopic and robotic resections significantly reduce the need for stoma creation.

Bookimed Expert Insight: Israeli oncology centers like Sourasky perform over 34,000 operations annually with a 90% success rate. High-volume centers often utilize Enhanced Recovery After Surgery (ERAS) protocols. These protocols help patients achieve primary anastomosis without needing a defunctioning stoma by prioritizing pre-operative preparation. Choosing a surgeon with over 20 years of experience, such as Dr. Gideon Goldman, further improves outcomes.

Patient Consensus: Patients note that temporary stomas are often part of the healing process to prevent leaks. They emphasize that minimally invasive surgery made their recovery faster and helped them avoid a permanent stoma.

What are the potential complications of sigmoid colectomy and how are they managed in Israeli hospitals?

Potential complications from sigmoid colectomy include anastomotic leaks, surgical site infections, and ileus. Israeli hospitals manage these risks through Enhanced Recovery After Surgery protocols. Highly trained teams at Joint Commission International-accredited facilities use laparoscopic and robotic techniques to minimize postoperative trauma and improve outcomes.

  • Anastomotic leaks: Managed with radiological drainage, antibiotics, or temporary diversion surgery.
  • Bowel dysfunction: Addressed through pelvic-floor physical therapy and dietary fiber titration.
  • Surgical prevention: Surgeons use robotic systems like Da Vinci for high-precision resection.
  • Postoperative care: Early mobilization and non-narcotic pain management prevent ileus and clots.

Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center report high success rates by combining surgical expertise with multidisciplinary oversight. Senior surgeons like Dr. Ron Greenberg and Dr. Joseph Klauzner specialize in minimally invasive colorectal procedures. This focus on laparoscopy significantly lowers the frequency of wound infections compared to traditional open surgery.

Patient Consensus: Patients emphasize the importance of walking soon after surgery to restart bowel function. Many recommend asking for stool tests if diarrhea occurs to rule out infections during recovery.

What staging work-up is done on arrival, and how quickly can surgery be scheduled?

Israeli oncology centers perform staging work-up within 1 to 2 days of arrival. Diagnostic protocols include PET-CT, chest and abdominal CT, and CEA bloodwork. Surgery for sigmoid adenocarcinoma is usually scheduled within 7 to 14 days once the multidisciplinary tumor board approves the treatment plan.

  • Diagnostic imaging: PET-CT and MRI assess tumor margins and potential distant metastasis.
  • Pathology review: Specialists verify existing biopsy slides to confirm the specific cancer grade.
  • Tumor markers: Carcinoembryonic antigen (CEA) blood tests establish a baseline for treatment monitoring.
  • Surgery timeline: Urgent or private cases can often proceed to surgery within 7 days.

Bookimed Expert Insight: While many believe surgery is the immediate step, Israeli centers like Sourasky Medical Center emphasize a multidisciplinary tumor board review first. Data shows these boards, featuring experts like Dr. Ron Greenberg and Dr. Ido Wolf, often refine the surgical approach. This can range from robotic-assisted resections to combining surgery with HIPEC for advanced cases, which significantly impacts long-term success rates.

Patient Consensus: Patients note it is vital to bring original pathology slides and digital imaging to avoid redundant diagnostic steps. Preparing these materials beforehand often helps secure an operation date within the first week of arrival.

How long should I plan to stay in Israel for sigmoid-cancer surgery and follow-up?

Patients should plan for a 10 to 14 day stay in Israel for sigmoid cancer surgery. This timeframe includes 3 to 7 days of hospitalization and one week of local recovery. Most centers clear patients for international travel approximately 10 days after the procedure.

  • Hospital stay: Expect 3 to 5 days for laparoscopic or robotic colorectal surgery.
  • Pre-surgical prep: Allow 2 to 3 days for imaging, blood work, and anesthesia evaluations.
  • Pathology window: Allow 7 to 14 days for tissue analysis to determine staging.
  • Travel clearance: Plan to stay 10 days post-surgery before boarding a long-haul flight.

Bookimed Expert Insight: While basic recovery takes 14 days, choosing centers like Sourasky or Assuta often allows for robotic-assisted surgery. Data shows these clinics handle over 30,000 operations annually. This high volume typically correlates with more efficient discharge protocols and faster returns of bowel function.

Patient Consensus: Patients note it is critical to stay nearby for the first 2 weeks. They emphasize building flexibility into travel plans in case pathology results or wound healing require extra time.

Dapatkan konsultasi gratis

Pilih cara terbaik agar kami menghubungi Anda